Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06939413

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

Led by Diabetes Solutions International · Updated on 2025-04-25

40

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

Sponsors

D

Diabetes Solutions International

Lead Sponsor

D

DexCom, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care. The main questions it aims to answer are: Does use of CGM \& RPM improve A1c? Does use of CGM \& RPM improve the percent of time spent with glucose levels between 70-180 mg/dl? Does the diabetes care management program improve diabetes related distress? Participants enrolled in the study will be wearing a CGM. Participants will be able to see the glucose readings from the CGM and see how their glucose level responds to food, physical activity, medications and daily life. The diabetes primary care team will be remotely monitoring the participant's glucose data from the CGM. They will reach out to the participant to make adjustments in treatment regimen as needed. Participants will answer a "Problem Areas in Diabetes"questionnaire that asks questions about diabetes related distress.

CONDITIONS

Official Title

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older with Type 2 diabetes
  • A1c > 8%
Not Eligible

You will not qualify if you...

  • Pregnancy (participant-reported)
  • Previous real time CGM use for more than 6 weeks in the last 3 months
  • Use of steroids
  • Active cancer treatment
  • Terminal illness
  • Dementia, mental impairment
  • Type 1 diabetes
  • End stage renal disease, on dialysis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Community Health Center of Franklin County

Greenfield, Massachusetts, United States, 01301

Actively Recruiting

Loading map...

Research Team

S

Sushma Reddy, MD

CONTACT

J

Jill Einstein, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here